BIOFRONTERA AG American Depositary Shares - Sponsored

YTD

ALL

Why Robinhood?

You can watch BFAGY and buy or sell other stocks, ETFs, and their options commission-free!

About BFAGY

Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos.

CEO

Hermann Lübbert, PhD

CEOHermann Lübbert, PhD

Employees

—

Employees—

Headquarters

Leverkusen, Nordrhein-Westfalen

HeadquartersLeverkusen, Nordrhein-Westfalen

Founded

1997

Founded1997

Employees

—

Employees—

BFAGY Key Statistics

Market cap

7.54M

Market cap7.54M

Price-Earnings ratio

5.41

Price-Earnings ratio5.41

Dividend yield

—

Dividend yield—

Average volume

2.42K

Average volume2.42K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.89

52 Week high$6.89

52 Week low

$1.50

52 Week low$1.50

BFAGY News

TipRanks 5h

Biofrontera AG’s Earnings Call Highlights Growth and Strategic Advances

Biofrontera AG ((DE:B8FK)) has held its Q4 earnings call. Read on for the main highlights of the call. Biofrontera AG’s recent earnings call conveyed a general...

TipRanks 7d

Biofrontera AG Prepares to Release 2024 Financial Report

Biofrontera ( (DE:B8FK) ) has provided an announcement. Biofrontera AG has announced the upcoming disclosure of its 2024 financial report, scheduled for public...